Post-mitotic neurons in the brain that re-enter the cell cycle quickly succumb to senescence, and this cell cycle re-entry and accumulation of resulting senescent neurons is more common in Alzheimer’s ...

A physician scientist is making strides in understanding the molecular origins of fatty liver disease, a leading cause of liver failure in the United States. An Indiana University School of Medicine ...

Alzheimer’s disease research and drug development is evolving at a rapid pace. Decades of research has led to the approval of the first disease-modifying drugs and new pathological discoveries. The ...

An Indiana University School of Medicine physician scientist is making strides in understanding the molecular origins of fatty liver disease, a leading cause of liver failure in the United States. By ...

Pain crises are a primary feature of sickle cell disease, triggering pain when crescent-shaped blood cells block the flow of oxygen to tissues. Now, a new study finds that these crises may be ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...